Concentrix Co. (NASDAQ:CNXC) Director Buys $100,051.20 in Stock

Concentrix Co. (NASDAQ:CNXCGet Rating) Director Kathryn Hayley bought 640 shares of the stock in a transaction dated Monday, April 25th. The stock was purchased at an average cost of $156.33 per share, with a total value of $100,051.20. Following the completion of the purchase, the director now directly owns 1,240 shares in the company, valued at approximately $193,849.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

NASDAQ CNXC opened at $153.46 on Thursday. The stock has a fifty day moving average of $180.16 and a 200-day moving average of $180.58. The stock has a market capitalization of $8.05 billion, a P/E ratio of 18.97, a price-to-earnings-growth ratio of 0.88 and a beta of 0.01. Concentrix Co. has a 52 week low of $141.38 and a 52 week high of $208.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.57 and a current ratio of 1.57.

Concentrix (NASDAQ:CNXCGet Rating) last announced its quarterly earnings data on Tuesday, March 29th. The company reported $2.85 EPS for the quarter, topping analysts’ consensus estimates of $2.71 by $0.14. Concentrix had a return on equity of 20.51% and a net margin of 7.40%. During the same quarter in the previous year, the firm earned $2.18 earnings per share. Equities research analysts forecast that Concentrix Co. will post 11.32 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 10th. Investors of record on Friday, April 29th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, April 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.65%. Concentrix’s dividend payout ratio (DPR) is presently 12.36%.

Separately, Zacks Investment Research cut Concentrix from a “hold” rating to a “sell” rating in a research note on Thursday, April 7th.

Institutional investors have recently made changes to their positions in the stock. HM Payson & Co. grew its stake in shares of Concentrix by 846.7% during the fourth quarter. HM Payson & Co. now owns 142 shares of the company’s stock worth $25,000 after purchasing an additional 127 shares during the period. CWM LLC acquired a new position in Concentrix in the fourth quarter valued at about $40,000. Rockefeller Capital Management L.P. grew its stake in Concentrix by 67.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 272 shares of the company’s stock valued at $47,000 after acquiring an additional 110 shares during the period. Counterpoint Mutual Funds LLC acquired a new position in Concentrix in the first quarter valued at about $57,000. Finally, AGF Investments LLC acquired a new position in Concentrix in the fourth quarter valued at about $88,000. 75.98% of the stock is owned by institutional investors and hedge funds.

About Concentrix (Get Rating)

Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions.

Featured Stories

Insider Buying and Selling by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.